"Efficiency of Preventive Interventions in Community Nursing to Improve Medication Adherence in Vulnerable Elderly"

NCT ID: NCT05469581

Last Updated: 2023-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

639 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to design and investigate the effectiveness of a set of preventive interventions by community nurses in outpatient care in treating vulnerable elderly people to improve the extent to which they follow the agreed recommendations of a doctor or pharmacist regarding taking medication.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We will conduct a randomized controlled trial to determine the effectiveness of preventive interventions to improve adherence in vulnerable elderly people.

The randomized controlled trial will include: vulnerable people over 65 years of age with preserved cognitive abilities who are receiving at least one medication for any medical condition and are being treated by an outpatient service; they live in their home environment, which in the first phase will show vulnerability and, at the same time, initial suboptimal adherence.

We will inform the subjects verbally and in writing about the course, purpose, and goals of the study and obtain their written consent for inclusion in the study. They will then be randomly assigned to two groups: experimental and control.

In the case of the experimental group, we will carry out a set of preventive interventions to support the improvement of medication adherence. The control group will receive regular nursing care from community nurses, to which we will add the so-called distractor.

We will determine the effectiveness of preventive interventions based on changes in self-efficacy and adherent behavior.

Data on adherence behavior and self-efficacy will be collected at the beginning of the study, at the end of the implementation of the set of preventive interventions, and three months after the end of the implementation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Noncommunicable Diseases Vulnerable Elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants were randomly assigned to two groups: experimental and control.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Interventions to be administered:

A set of preventive interventions to improve adherence in vulnerable elderly people (We will not administer any medications in the research):

* reviewing the list of medications, delivery of an ordered list of medications and checking medication regimen understanding;
* delivering a leaflet on the correct/safe taking of medication, discussion, explanation, and verification of understanding of the content;
* a counseling about the importance of adherence;
* handing over the medication dispenser (if the elderly person does not have one yet),
* delivering of a personal medication card, which shows the timeline of taking prescribed medication.

Group Type EXPERIMENTAL

A set of preventive interventions to improve adherence in vulnerable elderly people

Intervention Type OTHER

* reviewing the list of medications, delivery of an ordered list of medications, and checking medication regimen understanding;
* delivering a leaflet on the correct/safe taking of medications, discussion, explanation, and verification of understanding of the content;
* a counseling about the importance of adherence;
* handing over the medication dispenser (if the elderly person does not have one yet),
* delivering of a personal medication card, which shows the timeline of taking prescribed medication.

Control group

Interventions to be administered:

\- review of the list of medication, delivery of an ordered list of medication, and counseling

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A set of preventive interventions to improve adherence in vulnerable elderly people

* reviewing the list of medications, delivery of an ordered list of medications, and checking medication regimen understanding;
* delivering a leaflet on the correct/safe taking of medications, discussion, explanation, and verification of understanding of the content;
* a counseling about the importance of adherence;
* handing over the medication dispenser (if the elderly person does not have one yet),
* delivering of a personal medication card, which shows the timeline of taking prescribed medication.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* vulnerable elderly 65years and older,
* vulnerable elderly with preserved cognitive abilities,
* vulnerable elderly receiving at least one medication for any medical condition,
* vulnerable elderly treated by a community nurse,
* community-dwelling vulnerable elderly,
* suboptimal adherent vulnerable elderly.

Exclusion Criteria

* vulnerable elderly with psychoses or dementia,
* vulnerable elderly with cognitive disorders,
* vulnerable elderly addicted to alcohol,
* vulnerable elderly addicted to illegal drugs,
* vulnerable elderly in the terminal phase of the disease (life expectancy less than 6 months).
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Martina Horvat

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Martina Horvat

RN, community nursing specialist, PhD student/candidat

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martina Horvat

Role: PRINCIPAL_INVESTIGATOR

University of Maribor, Faculty of Health Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Maribor, Faculty of Health Sciences

Maribor, Styria, Slovenia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Slovenia

References

Explore related publications, articles, or registry entries linked to this study.

George J, Mackinnon A, Kong DC, Stewart K. Development and validation of the Beliefs and Behaviour Questionnaire (BBQ). Patient Educ Couns. 2006 Dec;64(1-3):50-60. doi: 10.1016/j.pec.2005.11.010. Epub 2006 Jul 14.

Reference Type BACKGROUND
PMID: 16843634 (View on PubMed)

Risser J, Jacobson TA, Kripalani S. Development and psychometric evaluation of the Self-efficacy for Appropriate Medication Use Scale (SEAMS) in low-literacy patients with chronic disease. J Nurs Meas. 2007;15(3):203-19. doi: 10.1891/106137407783095757.

Reference Type BACKGROUND
PMID: 18232619 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

39641

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.